Related Experiment Video
Updated: Feb 8, 2026
07:49
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
2.0K
Overactive Bladder is a Distress Symptom in Heart Failure
1Red Cross College of Nursing, Chung-Ang University, Seoul, Korea.
International Neurourology Journal
|July 12, 2018
Summary
Heart failure (HF) is linked to increased urinary incontinence (UI) and overactive bladder (OAB). Medications for HF may worsen these urinary symptoms, requiring further investigation into their combined impact.
Area of Science:
- Cardiology
- Urology
- Geriatrics
Background:
- Heart failure (HF) prevalence is rising globally due to aging populations.
- HF significantly impacts patient quality of life and incurs substantial economic costs.
- Urinary incontinence (UI) and overactive bladder (OAB) affect up to 50% of HF patients, yet their relationship with HF is under-researched.
Purpose of the Study:
- To review the existing literature on the association between heart failure (HF) and urinary symptoms like UI and OAB.
- To explore potential pathophysiological links and medication-related factors contributing to urinary issues in HF patients.
Main Methods:
- A comprehensive literature review was performed.
- Searched PubMed, Embase, and Cochrane databases for publications from January 2000 to November 2017.
- Focused on studies investigating the relationship between HF, UI, and OAB.
Main Results:
- Heart failure (HF) is a significant public health issue associated with a higher risk of UI and OAB.
- HF pathophysiology may directly contribute to urinary symptoms.
- Common HF medications (diuretics, ACE inhibitors, ARBs) might exacerbate urinary problems.
Conclusions:
- HF is a growing concern with increased risk for UI and OAB comorbidities.
- Medications prescribed for HF symptom management could potentially worsen urinary symptoms.
- Further research is needed to elucidate the impact of UI and OAB on the HF illness trajectory.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
975
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
975
01:17Pathophysiology of Heart Failure
3.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.8K
01:27Heart Failure I: Introduction
924
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
924
01:22Heart Failure VI: Adjunct Therapies
368
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
368
01:22Heart Failure Drugs: Diuretics
990
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
990
01:30Heart Failure V: Medical Management
342
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
342